Opportunity Information: Apply for CDC RFA DD09 9090201SUPP12
Apply for CDC RFA DD09 9090201SUPP12
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Population Based Surveillance for Hemoglobinopathies" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.184 Disabilities Prevention.
- This funding opportunity was created on May 11, 2012 and posted on May 11, 2012.
- Applicants must submit their applications by Jun 11, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 6 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The following recipients may submit an application Only awardees that are currently funded under CDC RFA DD09 909, Population Based Surveillance for Hemoglobinopathies Public Health Foundation Enterprises, Inc, Florida Department of Health, Georgia State Department of Community Health, Michigan Department of Community Health, North Carolina State Department of Health and Human Services, Pennsylvania State Department of Health.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC) funding opportunity titled "Population Based Surveillance for Hemoglobinopathies" (Funding Opportunity Number CDC-RFA-DD09-9090201SUPP12) is a discretionary grant program offered through a cooperative agreement. Its core purpose is to provide financial assistance so that recipients can complete objectives that support improved health outcomes and quality of life for people living with hemoglobinopathies, such as sickle cell disease and thalassemias. Because this is framed as a cooperative agreement rather than a standard grant, it generally implies a closer working relationship between the CDC and funded recipients, with CDC involvement in shaping or supporting program activities to ensure the surveillance and related objectives are carried out effectively.
The opportunity sits within the health funding activity category and is associated with CFDA number 93.184 (Disabilities Prevention). The program anticipates making up to six awards. No cost sharing or matching requirement is listed, meaning applicants are not required to contribute non-federal funds as a condition of receiving support. The posting and creation date for the opportunity were both May 11, 2012, with an original and current closing date of June 11, 2012, and an archive date of July 11, 2012. The award ceiling and award floor are both shown as 0 in the source data, which typically indicates that specific funding ranges were not provided in that summary field and would normally be detailed in the full announcement or tied to continuation/supplement amounts.
Eligibility for this particular opportunity is highly restricted. It is not open to the general public, universities, or most other entities. Only awardees already funded under the earlier CDC RFA DD09-909, "Population Based Surveillance for Hemoglobinopathies," are permitted to apply. The eligible recipients listed are Public Health Foundation Enterprises, Inc., and the state health agencies for Florida, Georgia, Michigan, North Carolina, and Pennsylvania. In practice, that restriction indicates this funding is designed as a continuation or supplement to existing, active surveillance infrastructure rather than an expansion to new states or new organizations. The emphasis is on enabling current awardees to finish or extend planned work that contributes to surveillance and related public health objectives for hemoglobinopathies.
From a programmatic standpoint, the focus on "population-based surveillance" signals an intent to strengthen the ability of participating jurisdictions to track hemoglobinopathy conditions across defined populations, understand disease burden, identify gaps in care, and support public health decision-making. While the summary does not enumerate specific required activities, the stated goal of improving health and quality of life implies that surveillance outputs are expected to inform prevention strategies, care coordination improvements, and broader public health interventions that can reduce complications and support better long-term outcomes for affected individuals.
For applicants or stakeholders needing help accessing the full announcement, the CDC points to its Procurement and Grants Office (PGo), Technical Information and Management Section (TIMS), with a phone contact for general submission inquiries at 770-488-2700.
Frequently Asked Questions (FAQs)
What is the title of this CDC funding opportunity?
The funding opportunity is titled "Population Based Surveillance for Hemoglobinopathies."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC-RFA-DD09-9090201SUPP12.
What type of funding mechanism is this (grant vs. cooperative agreement)?
This opportunity is offered through a cooperative agreement, which typically indicates closer collaboration between the CDC and funded recipients compared to a standard discretionary grant. In practice, CDC involvement may include supporting and helping shape program activities so the surveillance-related objectives are carried out effectively.
What is the main purpose of this opportunity?
The purpose is to provide financial assistance so recipients can complete objectives that support improved health outcomes and quality of life for people living with hemoglobinopathies, including sickle cell disease and thalassemias.
What health conditions are included under hemoglobinopathies for this program?
The summary references hemoglobinopathies such as sickle cell disease and thalassemias.
What does "population-based surveillance" mean in this context?
Based on the summary, "population-based surveillance" refers to strengthening the ability of participating jurisdictions to track hemoglobinopathy conditions across defined populations, understand disease burden, identify gaps in care, and support public health decision-making.
How is this opportunity categorized?
It sits within the health funding activity category.
What CFDA number is associated with this opportunity?
The associated CFDA number is 93.184 (Disabilities Prevention).
How many awards does the CDC anticipate making?
The program anticipates making up to six awards.
Is cost sharing or matching required?
No cost sharing or matching requirement is listed. That means applicants are not required to contribute non-federal funds as a condition of receiving support.
When was the opportunity posted?
The posting date is May 11, 2012 (the creation date is also May 11, 2012).
What were the closing and archive dates?
The original and current closing date are both listed as June 11, 2012. The archive date is July 11, 2012.
Is this opportunity currently open for applications?
Based on the dates provided (closing date June 11, 2012; archive date July 11, 2012), this opportunity is not open.
What are the award ceiling and award floor amounts?
The award ceiling and award floor are both shown as 0 in the source data. This typically indicates that specific funding ranges were not provided in that summary field and would normally be detailed in the full announcement or tied to continuation/supplement amounts.
Who is eligible to apply?
Eligibility is highly restricted. Only awardees already funded under the earlier CDC RFA DD09-909, "Population Based Surveillance for Hemoglobinopathies," are permitted to apply.
Is this opportunity open to the general public, universities, or new organizations?
No. The summary indicates it is not open to the general public, universities, or most other entities. It is limited to specific existing awardees.
Which specific organizations/agencies are listed as eligible recipients?
The eligible recipients listed are Public Health Foundation Enterprises, Inc., and the state health agencies for Florida, Georgia, Michigan, North Carolina, and Pennsylvania.
Does this opportunity support expansion to new states or jurisdictions?
The restriction to existing awardees indicates this funding is designed as a continuation or supplement to existing surveillance infrastructure rather than an expansion to new states or new organizations.
What kinds of outcomes or uses of surveillance data are implied by the summary?
While specific required activities are not enumerated in the summary, the stated goal of improving health and quality of life implies that surveillance outputs are expected to inform prevention strategies, care coordination improvements, and broader public health interventions that can reduce complications and support better long-term outcomes.
Where can applicants or stakeholders get help accessing the full announcement?
The CDC points to its Procurement and Grants Office (PGo), Technical Information and Management Section (TIMS).
Is there a phone number for general submission inquiries?
Yes. For general submission inquiries, the phone contact listed is 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: Transitional Living Program and Maternity Group Homes
Previous opportunity: Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD09 9090201SUPP12
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD09 9090201SUPP12) also looked into and applied for these:
| Funding Opportunity |
|---|
| State Based Surveillance for Hemoglobinopathies Apply for CDC RFA DD10 10170201SUPP12 Funding Number: CDC RFA DD10 10170201SUPP12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Zimbabwe Prevention of Mother to Child Transmission of HIV (PMTCT) Program Phase II Apply for RFA 613 12 000001 Funding Number: RFA 613 12 000001 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $60,000,000 |
| National Institute on Aging Analysis of Alzheimers Disease Genome Sequencing Project Data U19 Apply for PAR 12 183 Funding Number: PAR 12 183 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Macroeconomic Aspects of Population Aging (R01) Apply for PAR 12 186 Funding Number: PAR 12 186 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pediatric Environmental Health Specialty Unit (PEHSU) Program Apply for CDC RFA TS09 9010301SUPP12 Funding Number: CDC RFA TS09 9010301SUPP12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $165,000 |
| Replication of a Public Health Information Exchange to Support Engagement in HIV Care Initiative Apply for HRSA 12 179 Funding Number: HRSA 12 179 Agency: Health Resources and Services Administration Category: Health Funding Amount: $600,000 |
| NIGMS National Centers for Systems Biology (P50) Apply for PAR 12 187 Funding Number: PAR 12 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Native Hawaiian Health Care Improvement Act Apply for HRSA 12 174 Funding Number: HRSA 12 174 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| RFA Zimbabwe Orphans and Other Vulnerable Children (OVC) Project Apply for SOL 613 12 000003 Funding Number: SOL 613 12 000003 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $20,500,000 |
| Grants to Support the Historically Black Colleges and Universities Health Services Apply for CMS 1I0 12 001 Funding Number: CMS 1I0 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for CMS 1H0 12 001 Funding Number: CMS 1H0 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Food Safety Modernization Act Integrated Food Safety Centers of Excellence Apply for CDC RFA CK12 1210 Funding Number: CDC RFA CK12 1210 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| The NIH Centers for Accelerated Innovations (U54) Apply for RFA HL 13 008 Funding Number: RFA HL 13 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| State and Regional Primary Care Associations (PCA) Cooperative Agreements Alabama and Pacific Islands Apply for HRSA 12 183 Funding Number: HRSA 12 183 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with the Chinese Center for Disease Control and Prevention Apply for CDC RFA GH12 1247 Funding Number: CDC RFA GH12 1247 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| Building Resilience Against Climate Effects in State, Territorial and Tribal Health Departments Apply for CDC RFA EH12 1202 Funding Number: CDC RFA EH12 1202 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| National Center for Child Traumatic Stress Category I Apply for SM 12 005 Funding Number: SM 12 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $6,000,000 |
| Project LAUNCH Apply for SM 12 009 Funding Number: SM 12 009 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $850,000 |
| Research Education Program for Laboratory Animal Medicine Veterinarians (R25) Apply for RFA OD 12 006 Funding Number: RFA OD 12 006 Agency: National Institutes of Health Category: Health Funding Amount: $112,000 |
| PPHF 2012 Viral Hepatitis, Early Identification, and Linkage to Care for Persons with Chronic HBV and HCV Infections Financed Solely by 2012 Prevention and Public Health Fund Apply for CDC RFA PS12 1209PPHF12 Funding Number: CDC RFA PS12 1209PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD09 9090201SUPP12", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.